2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Christina M. Annunziata, MD, PhD

Principal Investigator
National Cancer Institute
10 Center Dr
Bldg 10, Rm 12N226
Bethesda, MD
USA 20892-1906

Papers:
517 High-throughput matrix screening in ovarian cancer cells identifies synergistic drug combinations with the second mitochondrial-derived activator of caspases (SMAC) mimetic birinapant (TL32711)